Cresco Labs Inc. (CNSX: CL)
Health Care · Pharmaceuticals · US
CA$1.13
+2.73% today · -38.9% 1Y
Cresco Labs Inc. (CNSX: CL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $305.58M and employs 2,900 people.
Over the last twelve months the share price has lost 38.9%, trading between 0.89 and 3.12.
Tweenvest scores Cresco Labs Inc. across four factors: quality 47/100, value 68/100, growth 8/100. Its strongest factor is value.
CL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $305.58M
- Revenue (TTM)
- $651.13M
- P/E
- —
- EPS
- -0.28
- Dividend yield
- —
- Beta (5Y)
- 1.72
- 52-week high
- CA$3.12
- 52-week low
- CA$0.89
- Avg volume (3M)
- —
- Shares outstanding
- 372.35M
- Employees
- 2,900
- Next earnings
- —
About Cresco Labs Inc.
Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL.
- ISIN
- CA22587M1068
- Listed since
- Aug 8, 1996
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.00 | +0.13% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.16 | +0.34% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.27 | -0.18% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.30 | -1.41% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.00 | -1.14% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.23% |
Figures last refreshed Aug 18, 2026.